Table 1.
Baseline Characteristic | |
---|---|
Male sex, n (%) | 20748 (33.4) |
Median age, y (IQR) | 38 (32–44) |
Median time since ART initiation, y (IQR) | 2.4 (0.9–4.9) |
Median CD4 count, cells/μL (IQR) | 438 (321–592) |
ART regimen, n (%) | |
First line | 60385 (97.4) |
Second line | 1584 (2.6) |
Prior history of tuberculosis, n (%) | 12033 (19.4) |
Appointment History | |
Median number of routine clinic visits, n (IQR) | 8 (4–11) |
Median number of clinical follow-up visits, n (IQR) | 2 (1–4) |
Median number of pharmacy refills, n (IQR) | 7 (4–11) |
Retention History | |
Median medication possession ratio, % (IQR) | 85.5 (75.2–94.0) |
Median number of visits missed by >14 days, % (IQR) | 20 (7.1–36.8) |
Patients with at least 1 episode of lost to follow-up, n (%) | 18946 (31.5) |
Abbreviations: ART antiretroviral therapy; IQR, interquartile range.